General - Press Releases

Date	Title	Company
03-Apr-2023	Legend Biotech Establishes Strategic Advisory Board	Businesswire
03-Apr-2023	Precision Biologics Announces Publication Of First-In-Human Phase 1 Clinical Trial With NEO-201	Businesswire
03-Apr-2023	Architect Equity Announces Sale of Solution Net Systems to Alstef Group	Businesswire
03-Apr-2023	Fytexia et Plant Advanced Technologies PAT annoncent la signature d’une collaboration stratégique en nutrition autour du programme N’GINS	Businesswire
03-Apr-2023	Aelis Farma Reports Its 2022 Annual Financial Results and Confirms Its 2023 Outlook	Businesswire
03-Apr-2023	Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Lincoln National Corporation (LNC) on Behalf of Investors	Businesswire
03-Apr-2023	Sumitomo Pharma Subsidiary Companies in the U.S., Including Sunovion, to Combine and Form Sumitomo Pharma America	Businesswire
03-Apr-2023	PharmaJet Partner Gennova Biopharmaceuticals Seeks Emergency Use Authorization in India for the First Needle-Free mRNA Vaccine Omicron Booster	Businesswire
03-Apr-2023	Napoli Shkolnik Congratulates Partner Harold P. Naughton Jr., on his Judicial Appointment to the U.S. District Court for the District of Massachusetts	Businesswire
03-Apr-2023	Alzamend Neuro Announces the Initiation of a Phase I/IIA Trial for Its Immunotherapy Vaccine (ALZN002) to Treat Mild to Moderate Dementia of the Alzheimer’s Type	Businesswire
03-Apr-2023	Zymeworks Announces Participation in Upcoming Investor Conferences	Businesswire
03-Apr-2023	Aviceda Announces 3 Presentations about AVD-104, its Lead Glyco-mimetic Nanoparticle, As a Novel Treatment for Geographic Atrophy from Macular Degeneration, at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, April 2023	Businesswire
03-Apr-2023	Bev Gregory Joins Alliant Insurance Services’ San Diego Employee Benefits Team	Businesswire
03-Apr-2023	AnHeart Therapeutics Appoints Edward Lang Jr. as Chief Business Officer	Businesswire
03-Apr-2023	Vertex and CRISPR Therapeutics Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia	Businesswire
03-Apr-2023	Vect-Horus Appoints Dr Jean-Manuel Péan as Chief Scientific Officer	Businesswire
03-Apr-2023	Scorpion Therapeutics Nominates STX-241 as Potentially Best-in-Class Fourth-Generation EGFR Inhibitor Development Candidate for the Treatment of Non-Small Cell Lung Cancer	Businesswire
03-Apr-2023	Agilent Announces High-Performance Cary 3500 Flexible UV-Vis System	Businesswire
03-Apr-2023	Rallybio Announces Acceptance of Abstract for RLYB212 at the 31st Congress of the International Society on Thrombosis and Haemostasis (ISTH)	Businesswire
03-Apr-2023	DigiLens Announces Launch of SRG+	Businesswire